Collaborative Advancement of Recovery Excellence
Translating science to service, powered by Gloo
In a meta-analysis of 157 clinical trials, contingency management programs were found to be the most beneficial treatment modality for cocaine use disorder among adults.
Since launching in September 2019, a partnership between the Hampden County (Massachusetts) Sheriff’s Department and CODAC Behavioral Healthcare has provided medication-assisted treatment to nearly 1,600 individuals, prompting interest in neighboring communities.
A study by Cordant Health Solutions and Northwest Integrated Health found that OUD patients who had been prescribed buprenorphine demonstrated higher retention rates and improved health outcomes when receiving medication at office visits instead of retail pharmacies.
A partnership with students at the University of Minnesota has resulted in a new way for the Hazelden Betty Ford Foundation to gain a better understanding the factors that put patients at greater risk for relapse.
Results of a clinical trial published by NIH on Wednesday showed that a combination of two medications—injectable naltrexone and oral bupropion—were safe and effective in the treatment of adults with moderate or severe methamphetamine use disorder.
Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.
A RAND study published in the Journal of Medical Internet Research finds that telehealth usage soared during the early months of the COVID-19 pandemic, but it was behavioral health diagnoses largely driving the surge, not COVID-related symptoms.
Psychiatry & Behavioral Health Learning Network Director Doug Edwards shares what’s ahead for the CARE initiative in 2021.
As the next wave of the COVID-19 pandemic arrives, it’s crucial for providers to enact staff rounding programs to understand the evolving concerns of their employees.
A massive takedown of telehealth providers suspected of billing for fraudulent claims is a sign that as organizations add telehealth services, developing a compliance infrastructure is a must, according to attorneys from Epstein Becker Green.